Corcept Therapeutics
CORT
#2463
Rank
HK$54.77 B
Marketcap
HK$500.44
Share price
-1.75%
Change (1 day)
-15.54%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): HK$11.76

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is HK$11.76. In 2025 the company made an earnings per share (EPS) of HK$7.37 a decrease over its 2024 EPS that were of HK$10.58.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$11.7659.53%
2025HK$7.37-30.37%
2024HK$10.58
2022HK$7.45-2.06%
2021HK$7.605.43%
2020HK$7.2110.84%
2019HK$6.5127.69%
2018HK$5.10-42.48%
2017HK$8.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36 345.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.16 250.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.15 1,959.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-33.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.43 201.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-HK$1.02-108.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.16-101.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-HK$0.71-106.00%๐Ÿ‡บ๐Ÿ‡ธ USA